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Abstract
Study Design: Retrospective comparative study.
Objectives: To assess the effect of vertebral body lavage (VBL) on (1) systemic blood pressure, (2) heart rate, and (3) oxygen
saturation following cement augmentation procedures for acute vertebral compression fractures (VCFs).
Methods: A total of 145 consecutive patients undergoing cement augmentation for acute VCF (mean age 74 + 12 years, age
range 42-96 years; 70% female; 475 levels treated) were allocated to the “lavage group” (n ¼ 61 patients; VBL prior to cement
application) and to the “control group” (n ¼ 84 patients, no VBL). Mean arterial blood pressure (MAP), heart rate, and oxygen
saturation were monitored immediately prior and 3 minutes after cement injection. Logistic regression analysis was performed
with DMAP10 mmHg before and after cement injection as the dependent outcome variable and demographic, radiographic, and
procedural factors as independent variables.
Results:MAP decreased by mean 3+ 7.3 mm Hg before and after cement injection in the “lavage group” and 9+ 10.5 mmHg in
the control group (P < .001). There were no significant differences in terms of heart rate and oxygen saturation before and after
cement application within each group, or between the 2 groups. Multivariate logistic regression analyses revealed VBL as an
independent factor influencing MAP (adjusted odds ratio: 3.49 [confidence interval, 1.16-10.50], P ¼ .03).
Conclusion: VBL prior to cement augmentation procedures reduces the hemodynamic response, most likely resulting from
decreased amounts of bone marrow substance displaced into the circulation thereby decreasing the risk of pulmonary fat
embolism syndrome.
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Introduction
The prevalence of osteoporotic vertebral compression fractures
(VCFs) has been reported to range between 7% and 46%world-
wide.1 Apart from the immense impact on the health care sys-
tem,2 VCFs are associated with a high degree of morbidity and
mortality in the elderly population.3,4 Although conservative
treatment of VCF may lead to a satisfactory midterm patient
outcome,5 percutaneous cement augmentation procedures with
polymethylmethacrylate (PMMA) cement present an effective
treatment option allowing for immediate pain relief,6 decreased
progression of kyphotic deformity,7 and lower incidence of
adjacent vertebra fractures in the osteoporotic spine.8 However,
vertebral augmentation procedures with PMMA may be asso-
ciated with a variety of potentially severe complications. The
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risk of cement leakage through the fracture gaps has been
reported to range between 3% and 74% in different studies,9
and subsequent neurological compromise from compression of
neurological structures occurred in 0.3% to 5%.9 Furthermore,
endovascular cement leakage causing pulmonary cement
embolism occurs in up to 25%. Finally, displacement of the
bone marrow particles from the injected cement into the vas-
cular system causes fat embolism in the downstream blood
vessels, most frequently occluding arterioles and capillaries
of the lung9 resulting in fat embolism syndrome.10 Three stra-
tegies have been developed to counteract cement leakage and
endovascular bone marrow displacement, including limited
cement volume injected per session,10,11 high viscosity of the
cement during the injection,12,13 and removal of bone marrow
from the vertebral body prior to cement injection.14 The latter
is achieved by a previously described technique of vertebral
body lavage (Figure 1). Vertebral body lavage has been shown
to decrease the injection forces thereby allowing the injection
of more viscous PMMA in a cadaveric study.15 Moreover, it
improved the systemic cardiovascular response and to
decreased the rate of pulmonary fat embolism in tissue biopsies
in an in vivo sheep model.15 Finally, a recent study revealed
lower vascular and cortical (ie, through the fracture gaps)
cement leakage rates in patients that previously underwent
vertebral body lavage as compared with a control group.16
However, there is a lack of clinical evidence regarding the
influence of vertebral body lavage on the systemic hemody-
namic response to cementation. We therefore asked whether
vertebral body lavage in patients undergoing cement augmen-
tation procedures for acute VCF leads to (1) decrease of sys-
temic blood pressure, (2) increased heart rate, and (3) drop of
oxygen saturation immediately after injection of PMMA
cement compared with a nonlavage control group.
Materials and Methods
A retrospective comparative study was conducted including 145
consecutive patients undergoing cement augmentation proce-
dures for acute VCF at our institution between January 2012
and August 2014. The mean age at surgery was 74+ 12 years
(range 42-96 years) and 70% of the patients were female. In
total, 475 levels were augmented in all patients. Patient charts
were reviewed for age, gender, level of fracture, number of
fractured vertebrae, number of cemented vertebrae, cardiovas-
cular, and pulmonary comorbidities, type of augmentation pro-
cedure, cement leakage (cortical defect, intradiscal, vascular) on
postoperative anterior-posterior and lateral standing radiographs,
and perioperative complications related to surgery. The indica-
tion for surgery was new onset of back pain (<6 weeks) with or
without recalled trauma, and the radiographic diagnosis of an
acute VCF. The age of VCFwas assessed bymagnetic resonance
imaging (MRI) of the affected spinal levels (thoracic, lumbar,
both). Presence of increased intraosseous signal intensity on
short-t-inversion recovery (STIR) sequences determined an
acute fracture. All patients undergoing cement augmentation
procedures for acute VCF within the predefined period were
included in the study. Patients with severe cardiopulmonary
comorbidities, systemic or local infection, known malignant dis-
ease, or compression of neurological structures with radicular or
spinal cord compression syndrome were excluded from the
study. The study was approved by the institutional review board.
Three different augmentation procedures were performed:
vertebroplasty (VP), kyphoplasty (KP), and stentoplasty (SP).
The procedures were performed by 4 senior spine surgeons. Two
surgeons routinely performed vertebral body lavage, whereas the
other 2 injected cement without prior lavage. Accordingly, all
patients were assigned to the “lavage group” and the “control
group.” The “lavage group” consisted of 61 patients with a total
of 203 vertebral levels treated, and the “control group” of 84
patients with a total of 273 vertebral levels treated (Table 1). The
groups did not differ significantly in terms of age, gender, num-
ber of fractured vertebra, number of cemented levels, location of
fracture (thoracic, thoracolumbar, lumbar), isolated VP, SP, or
cardiovascular comorbidities. There were more KP procedures
Figure 1. Schematic illustration of the setup of vertebral body lavage
is shown. Two Jamishidi cannulas are placed into the vertebral body
(bipedicular access) to flush the vertebral body with 30 mL of saline
solution. For this purpose, one syringe filled with 10 mL saline solution
is attached to one cannula (left), whereas a second empty syringe is
attached to the contralateral cannula (right). Vacuum is applied on the
empty syringe thereby rinsing the vertebral body with saline solution
and removing bone marrow particles from the vertebral body. This
procedure is repeated three times. Positive pressure on the syringe
filled with saline solution has to be avoided to not mimic the effect of
direct cement injection and to prevent displacement of bone marrow
and fat into the circulation.
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performed in the “lavage group” whereas the number of VP and
SP of at least 1 vertebra did not differ significantly between the
2 groups (Table 1).
All procedures were performed under general anesthesia and
systemic blood pressure was monitored invasively with an arter-
ial line. Mean arterial pressure (MAP) was documented directly
prior to cement injection and 3 minutes after the injection was
completed. The anesthesia protocols were evaluated by an
anesthetist for blood pressure, vascular or cardiac complications,
the need of catecholamines following cement injection, and
postoperative treatment on the intensive care unit.
The surgical technique has been described in detail previ-
ously.16 Briefly, all procedures were performed under general
anesthesia with the patient positioned prone on a radiolucent
operating table. Bipedicular Jamishidi needles (T-Lok Bone
Marrow Biopsy Needle, Argon Medical Devices, Frisco, TX,
USA; 8 gauge, 16 inches) were inserted under biplanar fluoro-
scopic guidance. For VCF treated with kyphoplasty or stento-
plasty, commercially available systems were used
(SYNFLATE–Vertebral Balloon System;VBS–Vertebral Body
Stenting System, respectively; Depuy Synthes, Bettlach, Swit-
zerland). Prophylactic cement augmentation (VP) of the intact
supra- and subjacent vertebra was performed in all patients. All
vertebrae in the “lavage group” underwent vertebral body
lavage prior to cement injection according to a previously
described protocol (Figure 1).15,16 Cement preparation was per-
formed according to themanufacturer’s recommendations (Ver-
tecemVþ, Depuy Synthes, Bettlach, Switzerland). Cement was
injected under lateral and posterior-anterior fluoroscopic gui-
dance to recognize cortical defect (ie, through the fracture gaps),
intradiscal, or endovascular cement leakage.Any type of cement
leakage detected on fluoroscopic images initiated immediate
termination of cement injection. In all other cases, cement injec-
tion was stopped when sufficient filling of the vertebral body
was achieved (endplate to endplate) as assessed by the treating
surgeon.
We performed a priori power analysis for the primary
research question regarding decrease of blood pressure after
cement application with a 2-tailed level of significance of
5%, beta error of 20%, known arterial blood pressure of
116.4 + 18.9 mm Hg before and 112.5 + 20.2 mm Hg after
cement injection,17 and a minimum detectable difference of
10 mm Hg resulting in a minimum sample size of 58 patients
per group.
Data with normal distribution was illustrated as means, stan-
dard deviations, ranges and confidence intervals. Comparisons
between the groups were calculated using the Mann-WhitneyU
test, and comparisons within one group using the Wilcoxon
signed rank test for continuous data. The Fisher’s exact test
was applied for binominal data. Multivariate, binary logistic
regression analyses were performed for the primary research
question with the dependent output variable defined as a min-
imumMAP drop of D10 mm Hg after cement injection, and the
independent variables vertebral body lavage, age, gender, num-
ber of cemented vertebra, cardiac comorbidities (ie, any type of
coronary heart disease, arrhythmogenic heart disease, cardio-
myopathy, congestive heart failure), level of cement augmen-
tation (thoracic, thoracolumbar, lumbar), number of fractured
vertebra, type of augmentation performed (VP, KP, VS),
cement leakage (endovascular and cortical leakage detected
on postoperative radiographs), and increase of heart rate
10/min using IBM SPSS V21.0.0 (Armonk, NY, USA).
Results
In the lavage group, 11 patients (18%) had a drop of MAP
(DMAP)10 mm Hg before and after cement injection. Mean
MAP decreased from 78 + 13.3 mm Hg (range, 57-126 mm
Hg; [confidence interval, CI, 75-82] before cement injection
to mean 75 + 13.5 mm Hg (range, 53-127 mm Hg; [CI, 71-
78]; P < .002) after cement injection (Table 2). In the control
group, 36 patients (43%) had DMAP 10 mm Hg before and
after cement injection. Mean MAP decreased from 82+ 11.9
mm Hg (range, 60-120 mm Hg [CI, 79-85]) to 73+ 13.9 mm
Hg (range, 47-120 mm Hg; [CI, 70-76]; P < .001). The mean
difference of MAP before and after cement injection (DMAP)
was 3+ 7.3 mm Hg (range, 0-30 mm Hg; [CI, 0.5-6.7]) in the
lavage group, and 9+ 10.5 mm Hg (range, 3 to 35 mm Hg;
[CI, 7-11]; P < .001) in the control group, respectively
(Table 2).
Table 1. Patient Demographics.
All Patients Lavage Group Control Group P
No. of patients, n 145 61 84 —
Age, years, mean+ SD (range) 74+ 12 (42-96) 75 + 12 (42-96) 74+ 12 (48-96) .703
Gender, % female 70 80 67 .080
No. of patients with >1 fractured vertebra 20 11 9 .145
No. of cemented vertebra, mean+ SD (range) 3+ 1.5 (1-6) 3 + 1.3 (1-6) 3 + 1.6 (1-6) .324
Thoracic 17 9 8 .213
Thoracolumbar 95 40 55 .403
Lumbar 33 12 21 .291
Isolated vertebroplasty 104 39 65 .057
Kyphoplastya 17 14 3 <.001
Stentoplastya 24 8 16 .236
aAt least 1 vertebra treated with kyphoplasty or stentoplasty.
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There were no significant differences in terms of heart rate
before and after cement injection in both groups. In the lavage
group, mean heart rate was 73+ 14.4/min (range, 45-110/min;
[CI, 70-76]) before cement application, and 73 + 13.8/min
(range, 45-105/min; [CI, 71-76]; P ¼ .722) after cement injec-
tion. In the control group, mean heart rate was 72+ 10.7/min
(range, 50-100/min; [CI, 69-75]), and 71 + 10.0/min (range,
50-95/min; [CI, 68-73]; P ¼ .075), respectively (Table 2).
Oxygen saturation did not change significantly before and
after cement injection in both groups. In the lavage group,
oxygen saturation was 99% + 1.3% (range, 95%-100%; [CI,
99.1-99.7]) and 99% + 1.6% (range, 95%-100%; [CI, 99.1-
99.7]; P ¼ .789). In the control group, oxygen saturation was
mean 99% + 1.7% (range, 90%-100%; [CI, 98.7-99.4]) prior
to cement application, and mean 99% + 1.3% (range, 95%-
100%; [CI, 99.0-99.5]; P ¼ .085), respectively (Table 2).
Multivariate, binary logistic regression with a minimum
MAP decrease of 10 mm Hg (DMAP 10 mm Hg) after
cement application as the dependent variable revealed vertebral
body lavage as the only independent factor with an impact on
systemic blood pressure (Table 3). If no vertebral body lavage
was performed prior to cement application, relative risk for a
decrease of MAP (DMAP 10 mm Hg) was increased by 3.49
(adjusted odds ratio, [CI, 1.16-10.50]; P ¼ .026). None of the
other factors evaluated in the analysis reached statistical
significance.
Discussion
Complications associated with percutaneous PMMA applica-
tion are known to be either local, such as cement extravasation
or cement leakage into the spinal canal, or systemic, involving
cardiopulmonary events such as pulmonary embolism.6 The
latter occur after elution of fat, bone marrow, or PMMA into
the epidural or vertebral venous system.15 In the current study,
the effect of vertebral body lavage prior to PMMA augmenta-
tion on subsequent cardiovascular changes was investigated.
The cardiovascular reaction to PMMA injection was char-
acterized by a significant decrease of MAP in the control group
3 minutes after PMMA application. Vertebral body lavage
could diminish this effect significantly, in terms of absolute
MAP decrease as well as in total numbers of patients affected.
Table 2. Primary Outcome Parameters.a
Parameter
Lavage Group Control Group
Before Cement Injection After Cement Injection Before Cement Injection After Cement Injection
Mean arterial blood pressure (mm Hg) 78 + 13.3
(57-126) [75-82]
75+ 13.5
(53-127) [71-78]b
82 + 11.9
(60-120) [79-85]
73 + 13.9
(47-120) [70-76]b
Mean heart rate (beats/min) 73 + 14.4
(45-110) [70-76]
73+ 13.8
(45-105) [71-76]
72 + 10.7
(50-100) [69-75]
71 + 10.0
(50-95) [68-73]
Oxygen saturation (%) 99 + 1.3
(95-100) [99.1-99.7]
99 + 1.6
(95-100) [99.1-99.7]
99 + 1.7
(90-100) [98.7-99.4]
99+ 1.3
(95-100) [99.0-99.5]
Difference of mean arterial
blood pressure, DMAP (mm Hg)
3+ 7.3 (0-30) [0.5-6.7] 9 + 10.5 (3 to 35) [7-11]c
aValues are presented as means+ standard deviations with range in parentheses and confidence intervals in brackets.
b P < .05 compared with before cement injection within each group.
cP < .001 compared with lavage group.
Table 3. Logistic Regression Analysis.a
Parameter P Adjusted Odds Ratio (95% CI)
Age .839 0.99 (0.95-1.04)
Gender .406 0.65 (0.23-1.79)
No. of cemented vertebra >1 .850 0.97 (0.72-1.31)
Thoracic .224 0.36 (0.07-1.86)
Thoracolumbar .287 0.58 (0.21-1.59)
Lumbar .345 0.42 (0.14-1.45)
Vertebroplasty .999 0.0 (—)
Kyphoplasty .999 0.0 (—)
VBS–Vertebral Body Stenting System .999 0.0 (—)
Vertebral body lavage .026 3.49 (1.16-10.50)
Vascular/osseous cement leakage .537 1.45 (0.45-4.73)
No. of fractured vertebra >1 .999 1.33 (0.34-5.11)
Heart rate .999 39.55 (—)
Cardiac comorbidities .908 0.94 (0.34-2.61)
a Binary, logistic regression analysis was performed with mean arterial pressure (MAP) drop >10 mm Hg as the dependent variable.
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According to previous research reports,15 the protective effect
might be explained by reduction of the bone marrow substance
in the vertebral body prior to PMMA application. In the animal
study oil-red O stained lung sections showed a significant
reduction of fat droplets after lavage.15 Even if we could not
reproduce this effect directly, due to the inability to perform
lung biopsies in our patients, it is likely that the pathophysio-
logical mechanisms in the sheep model are similar to the
effects observed in this study. In contrast to other studies
reporting a decrease of oxygen partial pressure after kypho-
plasty,17,18 these findings were not reproduced in the current
study. In accordance to these studies, however, the current
study also did not reveal significant changes in heart rate.17
While several factors intuitively influence cardiovascular
reactions, such as the number of vertebral bodies augmented,
type of procedure (VP/KP/SP) or percentage filling,9,11 multi-
variate analysis demonstrated vertebral body lavage to be the
only factor influencing hemodynamic response. Furthermore,
radiologically verified intravenous cement leakage, which may
be an alternate cause for pulmonary embolism, was not
detected as an independent factor for drop of systemic blood
pressure. This may be explained by the fact that the surgeon
stops PMMA injection as soon as first signs of venous leakage
are present under fluroscopy. Thus, our results support the
hypotheses that an increase in intravertebral pressure alone,
resulting in a displacement of fat and bone marrow substance
into the systemic circulation may be the source for cardiopul-
monary complications.15 Therefore, “pressure reducing”
injection methods such as stepwise injection or the use of
high-viscosity cement may reduce cardiopulmonary
complications.13,14
This study has several limitations. First, we cannot provide
proof that the lower incidence of MAP drop after cement injec-
tion with prior vertebral body lavage is due to a decreased rate
of pulmonary fat embolism. In this retrospective study, no
intraoperative echocardiogram was performed to objectify
increased amounts of fat in the circulation, and lung biop-
sies—as previously done in an in vivo sheep model—were not
conducted.15 However, there were no significant differences in
terms of radiologically visible vascular cement leakage
between the two groups and vascular cement leakage was not
identified as a risk factor for MAP drop as an alternative
mechanism. Second, the authors did not assess whether differ-
ent surgical techniques (VP, KP, SP) directly affected the
observed effects. Previous studies report lower rates of cardi-
opulmonary complications when performing KP instead of VP
alone likely due to decreased forces required during the cement
injection process.17,19 However, division of this patient series
in subgroups would have jeopardized statistical power.
Furthermore, all patients underwent prophylactic cement aug-
mentation of the supra- and subjacent intact vertebra using the
VP technique. Thus, there were no isolated KP or SP proce-
dures allowing for procedure specific stratification. Finally,
although this cannot completely rule out this limitation as a
potential source of bias, none of the applied augmentation pro-
cedures were found statistically as independent factors
affecting the hemodynamic response. Third, although there
were patients with significant drop in MAP in both groups,
none of these patients in this consecutive series died or had
other clinically relevant complications. The protective effect of
vertebral body lavage might be of particular importance in
patients with a lower threshold for significant acute respiratory
or heart failure.
The surgical setup using a bipedicular access to the vertebral
body, applying a vacuum with a syringe on one side thereby
rinsing the vertebral body with saline from the other side,
proved to be feasible (Figure 1).15,16 No cardiovascular side
effects associated with vertebral body lavage were registered
(eg, reducing systemic blood volume by intraosseous aspira-
tion), therefore this technique appears to be safe in a clinical
setting. In addition to the beneficial effect on MAP as observed
in the current study, a previous study using the same technique
found improved filling pattern, with significantly higher per-
centage of “coast-to-coast” filling and a significant reduction of
radiologically visible venous leakage.16
In conclusion, vertebral body lavage before PMMA applica-
tion results in a reduced hemodynamic response, most likely due
to a decrease of the embolic load. It is a simple and cost-effective
technique to increase the safety of percutaneous PMMA aug-
mentation techniques, like vertebro- and kyphoplasty, which
may ultimately prevent potentially life-threatening complica-
tions in patients with impaired cardiopulmonary function.
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